AMN082, the first selective metabotropic glutaniate receptor subtype 7 agonist: Activation of receptor signaling via an allosteric site in the transmembrane domain

被引：0
|
作者：
Mitsukawa, K [1 ]
Yamamoto, R [1 ]
Nozulak, J [1 ]
Ofner, S [1 ]
Pescott, O [1 ]
Lukic, S [1 ]
Stoehr, N [1 ]
Urwyler, S [1 ]
Kuhn, R [1 ]
Herrling, P [1 ]
Cryan, JF [1 ]
Flor, PJ [1 ]
机构：
[1] Novartis Pharma AG, Novartis Inst BioMed Res, Neurosci Res, CH-4002 Basel, Switzerland
来源：
NEUROPHARMACOLOGY | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
087
引用
收藏
页码：258 / 258
页数：1
相关论文
共 42 条
  • [11] Impact of the metabotropic glutamate receptor7 (mGlu7) allosteric agonist, AMN082, on fear learning and memory and anxiety-like behavior
    Kotlinska, Jolanta H.
    Lopatynska-Mazurek, Malgorzata
    Gawel, Kinga
    Gabka, Patrycja
    Jenda-Wojtanowska, Malgorzata
    Kruk-Slomka, Marta
    Marszalek-Grabska, Marta
    Danilczuk, Zofia
    Kedzierska, Ewa
    Talareka, Sylwia
    Listos, Joanna
    Gibula-Tarlowska, Ewa
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 858
  • [12] Metabotropic glutamate 7 receptor agonist AMN082 inhibits glutamate release in rat cerebral cortex nerve terminal
    Wang, Che Chuan
    Kuo, Jinn Rung
    Huang, Shu Kuei
    Wang, Su Jane
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 823 : 11 - 18
  • [13] The influence of repeated administration of the selective mGluR7 allosteric agonist AMN082 on GABA synthesis and GABA-B receptor expression in mice
    Wieronska, J. M.
    Branski, P.
    Nowak, G.
    Pilc, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S249 - S250
  • [14] Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death
    Domin, Helena
    Jantas, Danuta
    Smialowska, Maria
    NEUROCHEMISTRY INTERNATIONAL, 2015, 88 : 110 - 123
  • [15] Contribution of the mGluR7 receptor to antiparkinsonian-like effects in rats: a behavioral study with the selective agonist AMN082
    Konieczny, Jolanta
    Lenda, Tomasz
    PHARMACOLOGICAL REPORTS, 2013, 65 (05) : 1194 - 1203
  • [16] The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling
    Bradley, Stefania Risso
    Uslaner, Jason M.
    Flick, Rose B.
    Lee, Ariel
    Groover, Kristina M.
    Hutson, Peter H.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2012, 101 (01) : 35 - 40
  • [17] Contribution of the mGluR7 receptor to antiparkinsonian-like effects in rats: a behavioral study with the selective agonist AMN082
    Jolanta Konieczny
    Tomasz Lenda
    Pharmacological Reports, 2013, 65 : 1194 - 1203
  • [18] Intra-accumbal administration of AMN082, a metabotropic glutamate receptor type 7 allosteric agonist, inhibits the acquisition but not the expression of morphine-induced conditioned place preference in rats
    Vatankhah, Mahsaneh
    Karimi-Haghighi, Saeideh
    Sarihi, Abdolrahman
    Haghparast, Abbas
    NEUROSCIENCE LETTERS, 2018, 681 : 56 - 61
  • [19] The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice
    Podkowa, Karolina
    Pilc, Andrzej
    Podkowa, Adrian
    Salat, Kinga
    Marciniak, Marcin
    Palucha-Poniewiera, Agnieszka
    NEUROPHARMACOLOGY, 2018, 141 : 214 - 222
  • [20] A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats
    Palucha-Poniewiera, Agnieszka
    Pilc, Andrzej
    BEHAVIOURAL BRAIN RESEARCH, 2013, 238 : 109 - 112
12345